This week is International Dark Sky Week. Lights that are aimed upwards or not properly capped illuminate the atmosphere and ...

At first, if a user had typed “is ted cruz…” into Google’s search bar it would have autosuggested “the zodiac killer.” But by April, that autosuggestion had gone away, despite the ...

With 2025 approaching, each zodiac sign needs to adapt new strategies to thrive. Aries must practice patience, Taurus should embrace flexibility, and Gemini needs to focus on completing tasks.

So, is astrology a deal-breaker in dating? Not quite--but it's definitely on people's minds. While 27% of singles always check a potential match's sign before deciding to connect, most take a more ...

SAN DIEGO, April 2, 2025 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs ...

Overview: Regulus Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing drugs targeting microRNAs to treat various diseases in the United States ...

Work pressures increase for many Chinese zodiac signs in the third lunar month of the Year of the Snake, which starts on March 29, while budgeting and windfalls are common themes as well.

These weekly horoscopes offer guidance on how to use astrology to navigate the coming week as well as insight into what the planets have in store for the coming week. Taking into consideration ...

You’ll spot Leo; it’s easily picked out by the “Sickle,” which looks like a large backward question mark punctuated by the bright star Regulus. AM Planets: Venus, Saturn, and Mercury ...

After weeks and weeks of tough astrology, we have a month of blessings coming, which will ease tension and help us all feel more excited about pursuing new horizons. March brought us a series of ...

The last eclipse of spring 2025 is happening on March 29, following the lunar eclipse earlier this month. The action will unfold over a period of about 20 minutes on Saturday morning ...

Shares of Regulus Therapeutics (NASDAQ:RGLS) spiked on Thursday after the microRNA-focused drug developer announced additional topline data from a Phase 1b trial for its lead asset, farabursen ...